Mario Campone

New England Journal of Medicine · 2008–2022

A researcher in the Science corpus: 15 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Who trusts Mario Campone overall

  1. A. Hanker
  2. Johan Rung

Papers from Mario Campone's perspective

Ordered by how strongly the researchers Mario Campone trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository (Nucleic Acids Res.)
  2. Statistical Methods for Meta‐Analysis
  3. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. (New England Journal of Medicine)
  4. Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes (Clinical Cancer Research)
  5. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. (Journal of Clinical Oncology)
  6. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  7. The epithelial-mesenchymal transition generates cells with properties of stem cells. (Cell)
  8. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. (Journal of the National Cancer Institute)
  9. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. (New England Journal of Medicine)
  10. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. (Journal of the National Cancer Institute)

Their papers